Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Justin Stebbing

Showing results (401-410 of 504) with videos related to

Pageof 51
Sort By:
Oncotarget|March 16, 2018
The benefit of tumor molecular profiling on predicting treatments for colorectal adenocarcinomasPhilip Carter, Costi Alifrangis, Pramodh Chandrasinghe, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 5, 2010
Reproducibility of [11C]choline-positron emission tomography and effect of trastuzumabLaura M Kenny, Kaiyumars B Contractor, Rainer Hinz, et al.
Oncotarget|March 31, 2018
Correction: The benefit of tumor molecular profiling on predicting treatments for colorectal adenocarcinomasPhilip Carter, Costi Alifrangis, Pramodh Chandrasinghe, et al.
Communications Biology|August 28, 2019
Cell-derived extracellular vesicles can be used as a biomarker reservoir for glioblastoma tumor subtypingRosemary Lane, Thomas Simon, Marian Vintu, et al.
Genome Research|December 25, 2015
TP53 regulates miRNA association with AGO2 to remodel the miRNA-mRNA interaction networkJonathan Krell, Justin Stebbing, Claudia Carissimi, et al.
Plos One|June 23, 2017
Correction: MSLN gene silencing has an anti-malignant effect on cell lines overexpressing mesothelin deriving from malignant pleural mesotheliomaOmbretta Melaiu, Justin Stebbing, Ylenia Lombardo, et al.
Molecular Cancer Therapeutics|August 5, 2017
The Tumor-Suppressor Protein OPCML Potentiates Anti-EGFR- and Anti-HER2-Targeted Therapy in HER2-Positive Ovarian and Breast CancerElisa Zanini, Louay S Louis, Jane Antony, et al.
Oncotarget|March 22, 2018
Investigating the benefits of molecular profiling of advanced non-small cell lung cancer tumors to guide treatmentsCosti Alifrangis, Philip Carter, Biancastella Cereser, et al.
Molecular Diagnosis & Therapy|April 12, 2012
The clinico-pathologic role of microRNAs miR-9 and miR-151-5p in breast cancer metastasisJonathan Krell, Adam E Frampton, Jimmy Jacob, et al.
Future Oncology (London, England)|June 1, 2014
The prognostic role of circulating tumor cells in heavily pretreated individuals with a low life expectancyJustin Stebbing, Victoria Harding, Catherine E Urch, et al.
Pageof 51

Showing results (401-410 of 504) with videos related to

Sort By:
Pageof 51
Oncotarget|March 16, 2018
The benefit of tumor molecular profiling on predicting treatments for colorectal adenocarcinomasPhilip Carter, Costi Alifrangis, Pramodh Chandrasinghe, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 5, 2010
Reproducibility of [11C]choline-positron emission tomography and effect of trastuzumabLaura M Kenny, Kaiyumars B Contractor, Rainer Hinz, et al.
Oncotarget|March 31, 2018
Correction: The benefit of tumor molecular profiling on predicting treatments for colorectal adenocarcinomasPhilip Carter, Costi Alifrangis, Pramodh Chandrasinghe, et al.
Communications Biology|August 28, 2019
Cell-derived extracellular vesicles can be used as a biomarker reservoir for glioblastoma tumor subtypingRosemary Lane, Thomas Simon, Marian Vintu, et al.
Genome Research|December 25, 2015
TP53 regulates miRNA association with AGO2 to remodel the miRNA-mRNA interaction networkJonathan Krell, Justin Stebbing, Claudia Carissimi, et al.
Plos One|June 23, 2017
Correction: MSLN gene silencing has an anti-malignant effect on cell lines overexpressing mesothelin deriving from malignant pleural mesotheliomaOmbretta Melaiu, Justin Stebbing, Ylenia Lombardo, et al.
Molecular Cancer Therapeutics|August 5, 2017
The Tumor-Suppressor Protein OPCML Potentiates Anti-EGFR- and Anti-HER2-Targeted Therapy in HER2-Positive Ovarian and Breast CancerElisa Zanini, Louay S Louis, Jane Antony, et al.
Oncotarget|March 22, 2018
Investigating the benefits of molecular profiling of advanced non-small cell lung cancer tumors to guide treatmentsCosti Alifrangis, Philip Carter, Biancastella Cereser, et al.
Molecular Diagnosis & Therapy|April 12, 2012
The clinico-pathologic role of microRNAs miR-9 and miR-151-5p in breast cancer metastasisJonathan Krell, Adam E Frampton, Jimmy Jacob, et al.
Future Oncology (London, England)|June 1, 2014
The prognostic role of circulating tumor cells in heavily pretreated individuals with a low life expectancyJustin Stebbing, Victoria Harding, Catherine E Urch, et al.
Pageof 51